FDA Watch: DOGE Changes at FDA Upend Approval Processes, Observers Say
Pre-submission and Q-Submission meetings apparently have been halted, for now
Pre-submission and Q-Submission meetings apparently have been halted, for now
Though needed to protect data and patient privacy, some in the industry say that more flexibility is needed
Why ongoing coaching and learning is required for laboratory sales reps—even experienced ones—to help labs meet their business goals
The rounds of funding to Clarapath, PreciseDx, and Precision Epigenomics come at a time when other M&A activity is seasonally slow
Recent government efforts to address increased cyberattacks in the healthcare space, and how your lab could benefit
Though payers’ adoption of AI has made reimbursement more challenging for labs, providers can also use AI to address these issues
The agency has approved fewer than 10 tests in the past three years, but a new pipeline of AI-powered products is expected to emerge soon
A guide to understanding, implementing, and benefiting from digital pathology and artificial intelligence in the clinical lab
A few months on from the historic CrowdStrike outage, what lessons can clinical labs take away from the incident?
How clinical laboratories and pathology groups can ensure that their digital pathology and AI workflows are HIPAA-compliant
What labs need to know about keeping patients’ data safe when using digital pathology and artificial intelligence-based solutions